Pfizer Ev To Operating Cash Flow from 2010 to 2026
| PFE Stock | EUR 23.44 0.07 0.30% |
EV To Operating Cash Flow | First Reported 2010-12-31 | Previous Quarter 19.09 | Current Value 18.14 | Quarterly Volatility 71.09726989 |
Check Pfizer financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pfizer's main balance sheet or income statement drivers, such as Discontinued Operations of 6.6 M, Interest Expense of 3.7 B or Selling General Administrative of 11.2 B, as well as many indicators such as Price To Sales Ratio of 2.16, Dividend Yield of 0.0727 or PTB Ratio of 1.85. Pfizer financial statements analysis is a perfect complement when working with Pfizer Valuation or Volatility modules.
Pfizer | Ev To Operating Cash Flow |
The Ev To Operating Cash Flow trend for Pfizer Inc offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Pfizer is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Pfizer's Ev To Operating Cash Flow Growth Pattern
Below is the plot of the Ev To Operating Cash Flow of Pfizer Inc over the last few years. It is a valuation metric comparing the company's enterprise value to its operating cash flow, indicating how many dollars of EV are generated for each dollar of operating cash flows. Pfizer's EV To Operating Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pfizer's overall financial position and show how it may be relating to other accounts over time.
| Ev To Operating Cash Flow | 10 Years Trend |
|
Ev To Operating Cash Flow |
| Timeline |
Pfizer Ev To Operating Cash Flow Regression Statistics
| Arithmetic Mean | 32.86 | |
| Geometric Mean | 18.07 | |
| Coefficient Of Variation | 216.40 | |
| Mean Deviation | 32.40 | |
| Median | 15.62 | |
| Standard Deviation | 71.10 | |
| Sample Variance | 5,055 | |
| Range | 299 | |
| R-Value | (0.38) | |
| Mean Square Error | 4,621 | |
| R-Squared | 0.14 | |
| Significance | 0.13 | |
| Slope | (5.33) | |
| Total Sum of Squares | 80,877 |
Pfizer Ev To Operating Cash Flow History
About Pfizer Financial Statements
Pfizer stakeholders use historical fundamental indicators, such as Pfizer's Ev To Operating Cash Flow, to determine how well the company is positioned to perform in the future. Although Pfizer investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pfizer's assets and liabilities are reflected in the revenues and expenses on Pfizer's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pfizer Inc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| EV To Operating Cash Flow | 19.09 | 18.14 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Pfizer Correlation against competitors. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.